Xilio Therapeutics, Inc. Share Price & Technical Analysis
XLO · $8.35 (+1.21%)
Healthcare / Biotechnology
$8.35
+1.21%
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumor…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
5% return in May, 15% avg return in past 3 year May month.
-8% return in 2026, -2% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -9% | -12% | 15% | -7% | 5% | – | – | – | – | – | – | – | -8% |
| 25 | -28% | 30% | -19% | 4% | 42% | -10% | -4% | 9% | 22% | -3% | -5% | -13% | 24% |
| 24 | 5% | 6% | 42% | -21% | 7% | -10% | 2% | -6% | -8% | 68% | -15% | -13% | 57% |
| 23 | 35% | 1% | -4% | 3% | -2% | -14% | 6% | 8% | -27% | 3% | -55% | -43% | -89% |
| 22 | -15% | -16% | -42% | -54% | -20% | -3% | -1% | -29% | 32% | -19% | 4% | -4% | -166% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of masked immuno-oncology therapies. The company's pipeline includes XTX501, a bispecific PD-1 / masked IL-2, for patients with metastatic non-small cell lung cancer; Efarindodekin alfa, an investigational, masked IL-12, that is in Phase 2 clinical trial for patients with advanced solid tumors; and Vilastobart, an investigational tumor-activated, Fc-enhanced, high affinity binding anti-CTLA-4 monoclonal antibody. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$46.97M
P/E ratio
—
52W high
$16.10
52W low
$6.47
Volume
21,450
Beta
-0.13
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Xilio Therapeutics, Inc. share price today?
- Xilio Therapeutics, Inc. (XLO) last traded around $8.35 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does XLO have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for XLO. Download the app for real-time alerts.
- How can I analyze Xilio Therapeutics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.